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Abstract: Objective
The aim is to report 10-year health-related quality of life (HRQOL) outcomes following
the treatment of oral squamous cell carcinoma (OSCC).
Study Design
Cross-sectional HRQOL surveys collated over a 13-year period for patients treated
from 1992 gave a cohort of 674 patients with OSCC who had undergone treatment with
curative intent. HRQOL measured using the UWQOL closest to 2 and 10 years.
Results
UWQOL data were available for 67% (154) of 230 patients alive at 10 years. Three-
quarters reported their overall QOL as good, very good or outstanding. Free-flap
surgery was the strongest predictor of overall QOL being less than good at 10 years. A
significant problem or dysfunction was reported by a minority of patients, ranging from
7% to 13% across the 12 UWQOL domains. At the group level the changes from 2
years to 10 years were minimal with some improvement observed in appearance,
chewing, mood and anxiety and deterioration in regard to swallowing. There was
considerable scatter in individual changes over time.
Conclusions
As a group, HRQOL at 10 years is similar to that at 2 years however at an individual
patient level domains were not so stable.
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Long-term HRQOL following oral cancer: 10-year outcomes are very important when 
reporting the results of treatment. 
This is the first study to report large numbers and to be able to look specifically at 
difference between two years and ten years.  
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Objective. The aim is to report 10-year health-related quality of life (HRQOL) outcomes 
following the treatment of oral squamous cell carcinoma (OSCC). 
Study Design. Cross-sectional HRQOL surveys collated over a 13-year period for patients 
treated from 1992 gave a cohort of 674 patients with OSCC who had undergone treatment 
with curative intent. HRQOL measured using the UWQOL closest to 2 and 10 years.  
Results. UWQOL data were available for 67% (154) of 230 patients alive at 10 years.  Three-
quarters reported their overall QOL as good, very good or outstanding. Free-flap surgery was 
the strongest predictor of overall QOL being less than good at 10 years.  A significant 
problem or dysfunction was reported by a minority of patients, ranging from 7% to 13% 
across the 12 UWQOL domains. At the group level the changes from 2 years to 10 years 
were minimal with some improvement observed in appearance, chewing, mood and anxiety 
and deterioration in regard to swallowing. There was considerable scatter in individual 
changes over time. 
Conclusions As a group, HRQOL at 10 years is similar to that at 2 years however at an 




































































Health related quality of life (HRQOL) is a key outcome following treatment for head and 
neck cancer (HNC). 1 Although there are numerous publications in this field 2 there are a few 
papers reporting on long-term HRQOL outcomes in HNC 3-9 and even fewer reporting 
specifically on oral cancer. 10,11 Previous literature has tended to consider ‘long-term’ in 
terms of several earlier years following diagnosis and treatment; however, ‘late-effects’ has 
emerged as an important issue and outcomes should be considered beyond five years.  The 
importance of long-term outcomes and survivorship is reflected in national documents and 
initiatives across all cancers.  Also, there is appreciation of late effects and how these might 
impact on HRQOL. 12 
 
Bjordal et al 3,4 reported high levels of disease and treatment related symptoms such as 
dryness in the mouth and mucus production and psychological distress (30% of 'cases' 
according to the GHQ-20), 7 to 11 years after radiotherapy treatment for HNC. We have 
reported quality of life 5-10 years after primary surgery for oral and oro-pharyngeal cancer, 
however this study was small (48 patients) and cross-sectional. 5 The findings suggested that 
long-term survivors tend to report a good or excellent quality of life, with outcomes similar to 
those at one year. This result is at variance with Mehanna 7 as their cohort showed a 
deterioration in overall QOL (life satisfaction) after 10 years, though they too had a small 
sample size and cross-sectional design. Yan and co-workers 11 reported QOL 8-year 
following oral cancer, in a prospective study with 30 long-term survivors.  Clinically and 
statistically significant improvements between diagnosis and 8 years were seen for pain, 
mood and anxiety, whereas problems with chewing, speech, shoulder mobility, and taste 
worsened. 
 
The findings from the small number of studies so far are inconclusive and the aims of this 
paper are to report the health-related quality of life outcome at around 10-years and compare 
10-year outcomes to those reported at two years in a larger number of oral cancer patients. 
 
MATERIAL AND METHODS 
Patients 
The population comprised all patients presenting to Aintree University Hospital with oral 


































































treated with palliative intent, those with cognitive impairment or living overseas were 
excluded.  
 
Variables and measurements 
The UWQOL questionnaire is well established 2 and from 1995 we have regularly used this 
to survey OSCC patients at various times after primary diagnosis. The UW-QOL v4 
questionnaire consists of 12 single item domains, with between 3 and 5 response options 
scaled evenly from 0 (worst) to 100 (best) according to response hierarchy. 13 UW-QOL 
domains are presented within two subscales, physical function and social-emotional, as 
derived from earlier work.14  The physical function score is the mean of the appearance, 
swallowing, chewing, speech, taste and saliva domain scores, while the social-emotional 
score is the mean of the pain, activity, recreation, shoulder, mood and anxiety domain scores. 
Subscale scores were computed so long as there were 4 or more domain scores available and 
published criteria used to identify which patients have a significant problem or dysfunction.15 
There is also a single item overall QOL question on the UWQOL v4 for which patients are 
asked to consider not only physical and mental health, but also other factors, such as family, 
friends, spirituality or personal leisure activities important to their enjoyment of life.   
 
For patients alive at 10 years their UWQOL record closest to 10 years was selected within a 
time window requirement of being at least 8 years on from baseline (primary surgery or 
diagnosis if no surgery). These records were all after year 2000 and hence UWQOL version 
4. To enable a comparison of UWQOL close to 2 and 10 years for patients alive at 10 years 
their UWQOL record closest to 2 years was selected within a time window of 12-36 months. 
Many patients around 2 years responded to earlier versions of the UWQOL in which the 
taste, saliva, mood and anxiety domains in particular were absent.  
 
Statistical analysis 
Fishers exact test was used to test for association of baseline categories with survival at 10 
years, and to overall QOL being less than good after 10 years. Responses to each UWQOL 
domain were summarised into three categories – dysfunction, best possible response and 
responses that fell between these two extremes. In regard to within-patient change data over 
time (2 and 10 years), the McNemar test (2 categories) or the McNemar-Bowker test (3 
categories) was used to test paired table symmetry. Cohen's kappa coefficient was used to 


































































agreement, 0.21-0.40 ‘fair’, 0.41-0.60 as ‘moderate’, 0.61-0.80 ‘good’ and >0.80 as ‘very 
good’. The Paired t- test was used to compare paired numerical UWQOL domain scores over 
time, and 95% confidence intervals for the mean change were computed.  The Wilcoxon  test 
was used to compare paired subscale scores.  
 
This study was approved by Aintree University Hospital Audit Department as part of annual 
surveys and data collected in routine care.  
 
RESULTS 
There were 674 eligible patients and their characteristics are shown in Table 1. Overall 
survival at 10 years was 34% (230/674), 95% CI 30.5-37.8%.  Baseline age, tumour staging, 
free-flap surgery and primary treatment were associated (p<0.001) with overall survival at 10 
years (Table 1).  UWQOL data closest to 10 years (and at least 8 years on) was available for 
67% (154/230), at a median (IQR) of 121 (117-125) months from baseline.  Free-flap surgery 
was the strongest predictor of overall QOL being less than good at 10 years (Table 1), 45% 
for patients with composite flaps, 26% with soft flaps and 14% without a free-flap.  Other 
negative prognostic trends were observed for advanced tumours and for patients earlier in the 
cohort, though it was noted that the use of composite flaps fell from 25% in 1992-6 to 12% in 
2002-4 and the use of any free-flap from 81% to 64%.  
 
A significant problem or dysfunction was indicated from the responses given by a minority of 
patients, ranging from 7% to 13% across the 12 UWQOL domains (Table 2).  Otherwise, 
there was a fairly even split in patient response between the best possible response (35% to 
50% across domains) and being somewhere between the two extremes (33% to 54%). Overall 
quality of life was good or better for 74% (112/151) and the median physical function and 
social-emotional subscale median scores were 80 and 83 respectively (Table 3).  
 
Tables 4 and 5 show UWQOL domain results for 113 patients with data close to 10 years (at 
least 8 years on) at a median (IQR) of 121 (117-124) months and close to 2 years (within 12-
36 months) at a median (IQR) of 25 (20-28) months. The main observation is that changes in 
the UWQOL results were quite similar at 2 and 10 years in regard to the domain 
categorisations (Table 4) and numerical mean domain scores (Table 5). Both tables suggested 
small improvements in appearance, chewing, mood and anxiety and deterioration in regard to 


































































generally fair to moderate, with slightly more agreement observed for physical function 
domains than for social-emotional domains (Table 4).  The standard deviations for individual 
change scores indicate considerable scatter between two year and ten-year scores (Table 5).  
 
In regard to overall QOL being less than good the agreement between 2 and 10 years was 
weak (kappa statistic of 0.21) and the increase observed overall (from 14%, 10/73 to 19%, 
14/73) was not statistically significant (McNemar test, P=0.45). Median (IQR) physical 
function subscale scores were 74 (66-91) at 2 years and 78 (64-91) at 10 years, P=0.50 
Wilcoxon paired test n=112; Median (IQR) social-emotional subscale scores were 83 (69-92) 
at 2 years and 83 (70-95) at 10 years, P=0.39 Wilcoxon paired test n=113.  
 
DISCUSSION 
There is a paucity of HRQOL data collected prospectively to 10 years following oral cancer. 
This is an important topic in respect to survivorship and late effects. Although our Unit has 
published outcomes research on both HRQOL 16 and survival following oral cancer 17 
longitudinal changes up to 10 years have not been reported before. Our longitudinal design 
allows comment on changes from 2 years to 10 years and this study has the strength of being 
a relatively large sample of responders (154 patients) with 10 year HRQOL data with an 
acceptable response rate 67%. The study has limitations and one of these is that the UWQOL 
was not collected at fixed time points during follow-up but as part of ‘annual’ surveys. Hence 
the use of time windows to capture data close to certain time points. Secondly, in this aging 
patient population no attempt has been made to account for other comorbidities which might 
impact negatively on HRQOL. The sample is one of survivorship, with those dropping out 
probably reporting worse HRQOL. Lastly, it is inevitable that the cohort is historical, 1992 to 
2004, and various new treatment strategies have emerged, such as Intensity-Modulated 
Radiation Therapy (IMRT) which could influence the long-term outcomes in more recently 
treated patients.  
 
The sample does reflect survivorship in so much as there are relatively few patients aged 65 
years and over at the time of treatment who are alive after 10 years and contributing UWQOL 
outcomes data, and especially so for those aged 75 years and over. Similarly, those with 
advanced stages of disease, having surgery and post-operative radiotherapy and those 


































































when treated. This might partly explain the relatively good survival rate and relatively 
consistent reported quality of life characteristics between 2 and 10 years.  
 
The long-term HRQOL outcomes we report appear relatively good across the domains of the 
UW-QOL in regard to dysfunction and high mean scores. Three-quarters stated their overall 
QOL to be good or better.  It is possible that some domain scores might expect to fall 
naturally with age, such as activity, chewing, taste and saliva, but we could not explore this 
further as relevant normative data for the UW-QOL over time does not exist. 14 
 
It is very difficult to compare directly the findings of this current study with previous papers 
as each has different case mix characteristics. Yan et al 11 reported change in UW-QOL 
scores from 1 year to eight years in 30 oral cancer survivors. In this time period patients 
reported clinically significant improvements in appearance, recreation, speech, saliva and 
anxiety whilst the other seven items remained stable. In a cross-sectional survey using the 
UW-QOL in 26 patients 14.7 years (range, 3 to 27 years) following for oral cancer treated 
when they were 40 years of age or less, reported that 77% percent rated their overall QOL as 
outstanding, very good, or good.10 Only radiotherapy seemed to adversely affect the overall 
QOL and the key domains affected were appearance, mood, saliva, and shoulder function. 
Long-term outcome with good to very good QOL was reported in 67 patients, two to ten 
years after preoperative chemoradiotherapy followed by surgery including microvascular 
reconstruction for advanced oral and oropharyngeal cancer. 6 In contrast a longitudinal 
assessment of 26 patients treated for advanced oral or oropharyngeal cancer with a mean of 
9.2 years follow-up, (range 8-11 years), reported a number of HRQOL domains worsened 
significantly (p < 0.01) in the long-term: emotional functioning, social functioning, 
swallowing, speech, taste/smell, dry mouth, sticky saliva and coughing. 8 However. this was a 
group who were treated with free-flap reconstruction and postoperative radiotherapy and this 
could account for the deterioration. In an assessment of 22 patients at 10-years post-treatment 
after organ-preservation treatment, long-term functional voice and speech problems were 
common with fewer complaints in those treated with IMRT than with conventional 
radiotherapy 18 and also seen in swallowing and reduced mouth opening. 19   
 
When comparing across HRQOL at two years and at ten years in our sample it is notable that 
in this cohort of patients there is relatively little change at the group level. At most the mean 


































































by dividing mean change by the standard deviation (SD) in pre-change data, and a ‘small’ 
effect represents about 0.20 of SD, a ‘moderate’ effect about 0.50 of SD and a ‘large’ effect 
about 0.80 of SD.  Our results at 1-2 years give domain SDs of around 20 and this would 
imply a ‘small’ mean change being equivalent to 4 units, a ‘moderate’ change of 10 units and 
a ‘large’ change of 16 units.  Ringash et al 21 defined a minimal important difference as the 
smallest difference that reflects a clinically important change in score and stated that most 
published minimal important difference estimates fell into the range 5-10% of the instrument 
range, which for us would imply mean changes of about 5-10 units. Thus, it is reasonable to 
suggest that the changes we observed between mean scores at 2 and 10 years were small and 
just bordering on being clinically significant. There were improvements in appearance, 
chewing, mood and anxiety and deterioration in regard to swallowing. Although, as a cohort, 
HRQOL appears  relatively stable after two-years, there is individual variation. The data 
shows considerable individual scatter in domain change scores (Table 5) and only fair to 
moderate agreement between 2 and 10 years regarding the 3 categories (Table 4, 
‘dysfunction’, ‘neither extreme’ ‘best possible’). It is hard to ignore that in Table 4 there was 
no Cohen’s kappa score of greater than 0.60, the generally held criteria for defining good 
agreement, and hence that there was considerable within-patient instability between the 
results seen at 2 years and at 10 years.  
 
CONCLUSION 
In conclusion, in the long-term most patients following oral cancer report a good or better 
overall QOL. Those alive at 10 years were survivors, with survival linked to the baseline 
characteristics, as those more elderly and with advanced cancer were lost to follow-up. Group 
level changes between 2 and 10 years were small with some just bordering on being clinically 
significant with improvements suggested in appearance, chewing, mood and anxiety, with 
deterioration in swallowing. Individual patient level changes were not so stable.  
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Table 1 Baseline characteristics and overall QOL for those alive at 10 years 
 
 




 less than good* 
P value** 
Median No. of 
months  to 
UWQOL 
questionnaire 
Baseline characteristics % n/N % n/N 
 TOTAL 34  230/674  26 39/151  121 





 1997-2001 35 94/269 24 16/67 121 
 2002-2004 31 53/173 12 3/26 115  





 Female 38 93/248 27 15/56 122 





 55-64 40 79/196 21 12/58 121 
 65-74 28 47/169 
24 8/33 119 
 75+ 13 18/137 





 Lower gum 32 24/76 25 3/12 120  
 Tongue (ant 2/3) 44 87/200 20 11/56 120  
 Floor of Mouth 32 69/215 20 9/45 121  
 Other 24 12/49 55 6/11 123 





Stage  Late (3-4) 24 80/339 35 17/49 121 
 NK  0/3      





 Surgery & RT 24 59/241 29 12/42 121  
 RT alone 8 5/66 0 0/2 108 





 Yes - soft 38 103/271 26 20/77 122 
 No flap 46 77/168 14 6/43 119 
P stage  Early (0-2) 51 131/258 <0.001 excl 
NK  
20 18/88 0.06 excl 
NK 
122 
(surgical cases)  Late (3-4) 28 93/333 34 21/61 121 
 NK 6 1/17  0 0/2  105 
NK: Not known 
 
*151 of 230 alive at 10 years had overall QOL recorded from at least 8 years (96 months) on.  
 
**Fishers exact test 
 
 
Table Click here to access/download;Table;10-year-QOL-final
tables.docx
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 physical function 
subscale 
Appearance 153 78.6 (1.6) 10%  16 53% 81 37% 56 
Swallowing 153 79.9 (2.2) 12%  19 34% 52 54% 82 
Chewing 151 71.9 (2.5) 7% 10 43% 65 50% 76 
Speech 153 81.1 (1.7) 7% 10 47% 72 46% 71 
Taste 152 74.6 (2.5) 9% 13 43% 65 49% 74 




Pain 153 83.0 (1.8) 9% 14 37% 56 54% 83 
Activity 153 73.4 (2.0) 12% 19 50% 77 37% 57 
Recreation 153 77.6 (1.8) 7% 11 54% 82 39% 60 
Shoulder 152 78.1 (2.4) 13% 19 33% 50 55% 83 
Mood 154 80.5 (2.0) 12% 18 39% 60 49% 76 
Anxiety 152 82.0 (1.8) 9% 13 39% 59 53% 80 
 3 
Table 3.  UWQOL subscale scores and overall QOL at 10 years for OSCC patients  
 
  
Physical function subscale score (0-100): 
<50 12% 19/153 
50-69 21% 32/153 
70-89 30% 46/153 
90-100 37% 56/153 
Median (IQR) score 80 (65-95), N=153 
Social-emotional function subscale score (0-100): 
<50 9% 14/154 
50-69 16% 24/154 
70-89 40% 61/154 
90-100 36% 55/154 
Median (IQR) score 83 (70-95), N=153 
Overall QOL:   
Very poor / Poor 7% 10/151 
Fair 19% 29/151 
Good 36% 54/151 
Very good/Outstanding 38% 58/151 
   
Good or better 74% 112/151 
 
154 of 230 alive at 10 years had UWQOL data recorded from at least 8 years (96 months) on.  












 TWO years   TEN years  Change Kappa 
coefficient of 
agreement (SE) 



















Appearance 101 10% 10 60% 61 30% 30 8% 8 54% 55 38% 38 0.08 0.32 (0.08) 
Swallowing 112 5% 6 39% 44 55% 62 13% 15 33% 37 54% 60 0.03 0.43 (0.07) 
Chewing 111 6% 7 55% 61 39% 43 5% 6 47% 52 48% 53 0.12 0.42 (0.08) 
Speech 112 3% 3 61% 68 37% 41 6% 7 52% 58 42% 47 0.18 0.55 (0.07) 
Taste 77 9% 7 36% 28 55% 42 6% 5 43% 33 51% 39 0.38 0.54 (0.09) 





Pain 107 8% 9 33% 35 59% 63 8% 9 34% 36 58% 62 >0.99 0.50 (0.08) 
Activity 100 4% 4 52% 52 44% 44 9% 9 48% 48 43% 43 0.19 0.19 (0.09) 
Recreation 107 8% 9 50% 54 41% 44 5% 5 52% 56 43% 46 0.62 0.43 (0.08) 
Shoulder 107 11% 12 22% 24 66% 71 10% 11 31% 33 59% 63 0.50 0.22 (0.08) 
Mood 74 11% 8 45% 33 45% 33 4% 3 42% 31 54% 40 0.02 0.36 (0.09) 









Table 5. UWQOL mean domain scores at 2 and 10 years 
 







Mean (SE)  Mean (SE) Mean (SD) 






Appearance 112 74.3 (1.9) 78.8 (1.8) 4.5 (21.5) 0.4, 8.5 0.03 
Swallowing 112 84.2 (1.9) 79.9 (2.5) -4.3 (25.0) -9.0, 0.4 0.07 
Chewing 111 66.2 (2.8) 71.2 (2.8) 5.0 (29.3) -0.6, 10.5 0.08 
Speech 112 79.9 (1.6) 80.1 (1.8) 0.2 (17.3) -3.1, 3.4 0.91 
Taste 77 80.4 (3.0) 76.9 (3.3) -3.5 (22.7) -8.7, 1.6 0.18 




Pain 113 83.2 (2.1) 82.5 (2.2) -0.7 (18.8) -4.2, 2.8 0.71 
Activity 112 77.5 (2.1) 75.5 (2.3) -2.0 (24.7) -6.6, 2.6 0.39 
Recreation 113 78.5 (2.1) 79.6 (2.0) 1.1 (21.2) -2.9, 5.1 0.58 
Shoulder 110 81.3 (2.9) 80.5 (2.6) -0.8 (27.8) -6.1, 4.4 0.76 
Mood 74 79.0 (2.9) 85.1 (2.3) 6.1 (25.8) 0.1, 12.1 0.05 
Anxiety 74 79.0 (2.9) 84.2 (2.3) 5.2 (24.6) -0.5, 10.9 0.08 
  
*paired t-test 
 
